InvestorsHub Logo
Followers 81
Posts 24737
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Monday, 05/20/2024 8:13:20 AM

Monday, May 20, 2024 8:13:20 AM

Post# of 27667
NKGN - 1.58/1.59 Up from 1.12

NKGen Biotech shares are trading higher after the company's SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer's disease.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.